Preview

Артериальная гипертензия

Расширенный поиск

Тахииндуцированная кардиомиопатия: клинико-патогенетические аспекты

Полный текст:

Аннотация

Рассматриваются современные взгляды на тахииндуцированную кардпомиопатию, возникающую вследствие повышения частоты сокращения предсердий или желудочков. Представлены данные экспериментальных и клинических исследований. В работе отражены вопросы патогенеза, клиническое значение, вопросы диагностики и лечения тахииндуцированной кардиомиопатии.

Об авторах

Э. Р. Бернгардт
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия


Е. В. Пармон
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия


Т. В. Трешкур
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия


Е. В. Шляхто
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия


Список литературы

1. Пармон E.B., Трешкур Т.В., Шляхто Е.В. Идиопатичеекие желудочковые нарушения ритма (анализ проблемы). Вестник Аритмологии 2003; 31: 60-69.

2. Кушаковский M.C. Аритмии сердца. СПб., ИКФ «Фолиант»; 1998., 640 с.

3. Gossage A.M., Braxton Hicks J. A. On auricular fibrillation. QJM 1913; 6: 435-440.

4. Brill I.C. Auricular fibrillation with congestive failure and no other evidence of organic heart disease. Am Heart J 1937: 13: 175-182.

5. Strain J.E., Grose R.M., Factor S.M., Fisher J.D. Results of endomyocardial biopsy in patients with spontaneous ventricular tachycardia but without apparent structural heart disease. Circulation. 1983; 68 (6): 1171-81.

6. Шляхто E.B., Трешкур Т.В., Пармон E.B. и др. Идиопатические желудочковые нарушения ритма: результаты проспективного наблюдения. Вестник Аритмологии 2004; 33: 5-11.

7. Whipple G.H., Sheffield L.T., Woodman E.G., Theophilis C., Friedman S. Reversible congestive heart failure due to chronic rapid stimulation of the normal heart. Proc N Engl Cardiovasc Soc 1962; 20: 39-40.

8. Меерсон Ф.З. Гиперфункция, гипертрофия, недостаточность сердца. М. Медицина; 1968, 388 с.

9. Ravens U., Davia К., Davies С.H., O'Gara P., Drake-Holland A.J., Hynd J.W. et al. Tachycardia-induced failure alters contractile properties of canine ventricular myocytes. Cardiovasc Res 1990; 32 (3): 613-62l.

10. Quiniou G., Chevalier J.M., Barhou F., Bire F., Clementy J. Tachycardia-induced cardiomyopathy, unusual and reversible cause ol left ventricular dysfunction: Report of 9 cases. Ann Cardiol Angeiol (Paris) 2000; 49 (5): 301-308.

11. Shinbane J.S., Wood M.A., Jensen D.N., Ellenhogen K.A., Fitzpatrick A.P., Scheinman M.M. Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies! Am Coll Cardiol 1997; 29 (4): 709-715.

12. McGuire M.A., Lau К.С., Davis L.M., Knight P., Uther J.B., Rossj D.L. Permanent junctional reciprocating tachycardia misdiagnosed as “cardiomyopathy”. Ausl N Z J Med 1991; 21 (2): 239-241.

13. Yu Y.H., Bilezikian J.P. Tachycardia-induced cardiomyopathy secondary to thyrotoxicosis: A young man with previously unrecognized Graves' disease. Thyroid 2000; 10 (10): 923-927.

14. Chang-Chretien K., Chew J.T., Judge D.P. Reversible dilated: cardiomyopathy associated with glucagonoma. Heart 2004; 90 (7): e44.

15. Chugh S.S., Shen W.K., Luria D.M., Smith H.C. First evidence of premature ventricular complex-induced cardiomyopathy: A potentially reversible cause of heart failure. J Cardiovasc Electrophysiol 2000; 11 (3): 328-329.

16. Singh B., Sudan D., Kaul U. Radiofrequency ablation for bundle branch reentrant tachycardia in a patient, with aortic valve replacement and left ventricular dysfunction. Indian Heart J 1998; 50 (5): 55l-553.

17. Vijgen J., Hill P., Biblo L.A., Carlson M.D. Tachycardia] induced cardiomyopathy secondary to right ventricular outflow tract ventricular tachycardia: Improvement of left ventricular systolic function after radiofrequenсу catheter ablation of the arrhythmia. J Cardiovasc Electrophysiol 1997; 8 (4): 445-450.

18. Singh B., Kaul U., Talwar K.K., Wasir H.S. Reversibility of "tachycardia-induced cardiomyopathy" following the cure of idiopathic left ventricular tachycardia using radiofrequency cnergy; Pacing Clin Electrophysiol 1996; 19 (9): 1391-1392.

19. Ott P., Kelly P.A., Mann D.E., Damle R.S., Reiter M.J., Lindefeld J. Tachycardia-induced cardiomyopathy in a cardiac transplant recipient: Treatment with radiofrequency catheter ablation. J Cardiovasc Electrophysiol 1995; 6 (5): 391-395.

20. Wilson J.R., Douglas P., Hickey W.F., Lanoce V., Fcrram N., Muhammad A., Reichek N. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: Cardiac effects Circulation 1987; 75 (4): 857-867.

21. Fuenmayor A.J., Fucnmayor A.M. Tachycardiomyopathy patients with and without subacute cardiac pathology. Experiences at the Cardiovascular Center of Merida, Venezuela. Arch Inst Cardiol Мех 1998: 68 (6): 515-520.

22. Wijffels M.C., Kirchhof C.J., Dorland R., Allessie M.A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 1; 92 (7): 1954-1968.

23. Zupan I., Rakovec P., Budihna N., Brecelj A., Kozelj M. Tachycardia-induced cardiomyopathy in dogs; relation between chronic supraventricular and chronic ventricular tachycardia. Inn J Cardiol 1996; 56 (1 ): 75-81.

24. Thackray S.D., Wille K.K., Nikitin N.P., Clark A.L., Kayc G.C., Cleland J.G. The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population. Eur Heart J 2003; 24 (12): 1143-1152.

25. Byrne M.J., Raman J.S., Alferness C.A., Esler M.D., Kaye D.N., Power J.M. An ovine model of tachycardia-induced degenerative dilated cardiomyopathy and heart failure with prolonged onset J Card Fail 2002; 8 (2): 108-115.

26. Мое G.W., Howard R.J., Grima E.A., Armstrong P.W. How does intermittent pacing modify the response to rapid ventricular pacing in experimental heart failure? J Card Fail 1995; 1 (3): 223-228.

27. Timek Т.А., Dagum P., Lai D.T., Liang D., Daughters G.T., Tibayan F. et al. Tachycardia-induced cardiomyopathy in the ovine heart: Mitral annular dynamic three-dimensional geometry. J Thorac Cardiovasc Surg 2003; 125 (2): 315-324.

28. Tomita M., Ikeguchi S., Kagawa K., Noda T., Nishigaki K., Furuta S., Gotoh K., Fujiwara H. Serial histopathologic myocardial findings in a patient with ectopic atrial tachycardia-induced cardiomyopathy. J Cardiol 1997; 29 (1 ): 37-42.

29. Spinale F.G., Holzgrefe H.H., Mukherjee R., Arthur S.R., Child M.J., Powell J.R. LV and myocyte structure and function after early recovery from tachycardia-induced cardiomyopathy. Am J Physiol 1995; 268 (2 Pt 2): H836-H847.

30. Jovanovic S., Grantham A.J,, Tarara J.E., Burnett J.C. Jr., Jovanovic A., Terzic A. Increased number of cardiomyocytes in sections from tachycardia-induced cardiomyopathic hearts. Int J Mol Med 1999; 3 (2): 153-155.

31. Spinale F.G., Grine R.C., TempeJ G.E., Crawford F.A., Zile M.R. Alterations iterations in the myocardial capillary vasculature accompany tachycarrdia-induced cardiomyopathy. Basic Res Cardiol 1992; 87 (1): 65-79.

32. ZellnerJ.L., Spinale F.G., Eble D.M., Hewett K.W. Crawford Alterations in myocyte shape and basement membrane in men with tachycardia-induced heart failure. Circ Res 1991; 69 (3): 590-600.

33. Tanaka R., Fulbright B.М., Mukherjee R., Burchell S.A., Crawford F.A., Zile M.R. et al. The cellular basis for the blunted ise to betaadrenergic stimulation in supraventricular tachycardia-incluced cardiomyopathy. J Mol Cell Cardiol 1993; 25 (10): 1215-1233.

34. Spinale F.G., Tempel G.E., Mukherjee R., Eble D.M., Brown R., Vacchiano C.A. et al. Cellular and molecular alterations in the beta ;rgic system with cardiomyopathy induced by tachycardia. Cardiovasc Res 1994; 28 (8): 1243-1250.

35. Eble D.M., Spinale.FG. Contractile and cytoskeletal it, structure, and mRNA levels with tachycardia-induced imyopathy. Am J Physiol 1995: 268 (6 Pt 2): H2426-H2439.

36. Balijepalli R.C., Lokuta A.J., Maertz N.A., Buck J.M., Haworlh R.A., Valdivia H.H. et al. Depletion of T-tubules and specific subcellular changes in sarcolemmal proteins in tachycardia-induced part failure. Cardiovasc Res 2003; 59(1): 67-77.

37. Takahashi M., Tsutsui H., Kinugawa S., Igarashi-Saito K., Yamamoto S., Yamamoto M. et al. Role of microtubules in the contractile dysfunction of myocytes from tachycardia-induced dilated cardiomyopathy. J Mol Cell Cardiol 1998; 30(5): 1047 1057.

38. Heinke M.Y., Wheeler C.H., Yan J.X., Amin V., Chang D., Einstein R. et al. Changes in myocardial protein expression В pacing-induced canine heart failure. Electrophoresis 1999: 20 (10): 2086-2093.

39. Heinke M.Y., Yao M., Chang D., Einstein R., dos Remedios C.G. Apoptosis of ventricular and atrial myocytes from pacing-induced canine heart failure. Cardiovasc Res 2001; 49 (1): 127-134.

40. Бокерия Л.А., Бескровнова Н.П., Цыпленкова В.Г. и др. Возможная роль апоптоза в возникновении аритмий у больных с пароксизмальными тахикардиями. Кардиология 1995:35: 52-56.

41. Brilla C.G. Aldosterone and myocardial fibrosis in heart failure. Herz 2000; 25: 299-306.

42. Grima E.A., Мое G.W., Howard R.J., Armstrong P.W. Recovery of attenuated baroreflex sensitivity in conscious dogs after revercal of pacing induced heart failure. Cardiovasc Res 1994; 28 (3): 384-390.

43. Shite J., Qin F., Mao W., Kawai H., Stevens S.Y., Liang С. Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy. J Am Coll Cardiol 2001; 38 (6): 1734-1740.

44. Dupuis J., Мое G.W., Cernacek P. Reduced pulmonary metabolism of endothelin-1 in canine tachycardia-induced heart failure. Cardiovasc Res 1998: 39 (3): 609-016. 45. Marin-Garcia J., Goldenthal M.J., Мое G.W., Selective endothelin receptor blockade reverses mitochondrial dysfunction in canine heart failure. J Card Fail 2002; 8 (5): 326-332.

45. Spinale F.G., Zellner J.L., Johnson W.S., Eble D.M., Munycr P. Cellular and extracellular remodeling with the development ad recovery from tachycardia-induced cardiomyopathy: Changes in fibrillar collagen, myocyte adhesion capacity and proteoglycans. J Mol Cell Cardiol 1996; 28 (8):1591-1608.

46. Мое G.W., Armstrong P. Pacing-induced heart failure: A model to study the mechanism of disease progression and novel therapy in heart failure. Cardiovasc Res 1999; 42 (3): 591-599.

47. Thorburn J., Xu S., Thorburn A., MAP kinase- and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells. EMBO J 1997; 16 (8): 1888-1900.

48. Wu Y., Bell S.P., Trombilas K., Witt C.C., Labeit S., LeWinter M.M., Grandzier H. Changes in titin isoform expression in pacing-induced cardiac failure give rise to increased passive muscle stiffness. Circulation 2002; 106 (11): 1384-1389.

49. Neagoe C., Kulke M., del Monte F., Gwathmey J.K., de Tombe P.P., Hajjar R.J., Linke W.A. Titin isoform switch in ischemic human heart disease. Circulation 2002; 196 (11): 1333-1341.

50. Sen L., Cui G., Fonarow G.C., Laks H. Differences in mechanisms of SR dysfunction in ischemic vs. idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2000: 279 (2): H709-H718.

51. Saavedra W.F., Paolocci N., St John M.E., Skaf M.W., Stewart G.C., Xie J.S. et al. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergelic uncoupling in the failing heart. Circ Res 2002; 90 (3): 297-304.

52. Lass A., Suessenbacher A,, Wolkart G,, Mayer B,, Brunner F. Functional and analytical evidence for scavenging of oxygen radicals by L-arginine. Mol Pharmacol 2002; 61 (5): 1081-1088.

53. Qin F., Shite J., Mao W,, Liang C,S. Selegiline attenuates cardiac oxidative stress and apoptosis in heart failure: Association with improvement of cardiac function. Eur J Pharmacol 2003; 461 (2-3): 149-158.

54. Мое G.W., Naik G., Konig A., Lu X., Feng Q. Early and persistent activation of myocardial apoptosis, bax and easpascs: Insights into mechanisms of progression of heart failure. Pathophysiology 2002: 8 (3): 183-192.

55. Schotten U., Greiser M., Benke D., Buerkel K., Ehrenleidt B., Slellbrink С. et al. Atrial fibrillation-induced atrial contractile dysfunction: A tachycardiomyopathy of a different son. Cardiovasc Res 2002; 53 (1): 192-201.

56. Hanna N., Cardin S., Leung T.K., Mattel S. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacinginduced congestive heart failure. Cardiovasc Res 2004; 63 (2): 236-244.

57. Cha T.J., Ehrlich J,R,, Zhang L,, Shi Y,F,, Tardif J,C., Leung T.K., Nattel S. Dissociation between ionic remodeling and ability tо sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation 2004: 109 (3): 412-418.

58. Khasnis A., Jongnarangsin K., Abela G. et al. Tachycardia-Induced Cardiomyopathy: A Review of Literature. Pacing Clin Electrophysiol. 2005: 28(7): 710-721.

59. Kim Y.H., Goldberger J., Kadish A. Treatment of ventricular tachycardia-induced cardiomyopathy by transcatheter radiofrequency ablation. Heart 1996; 76 (6): 550-552.

60. Nakamura R., Egashira K., Machida Y., Hayashidani S., Takeya M., Utsumi H. et al. Probucol attenuates left ventricular dysfunction and remodeling in tachycardia-induced heart failure: Roles of oxidative stress and inflammation. Circulation 2002: 106 (3): 362-367.

61. Suzuki Y., Tanaka M., Sohmiya M., Yoshida T., Okamoto K. Antioxidant properties of carvedilol: Inhibition of lipid peroxidation, protein oxidation and superoxide generation. Neurol Res 2003; 25 (7 ):749-753.

62. Zhang S., Sun Z., Liu L. Hasichaonu. Carvedilol attenuates СРВ-induced apoptosis in dog heart: Regulation of Fas/FasL and caspase-3 pathway. Chin Med J (Engl) 2003: 116 (5): 761-766.

63. Yuan Z., Shioji K., Kihara Y., Takenaka H., Onozawa Y., Kishimoto C. et al. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: Anti-inflammatory effects associated with antioxidant property. Am J Physiol Heart Circ Physiol 2004; 286 (1): H83-H90.

64. Chin B.S., Langford N.J., Nuttall S.L., Gibbs C.R., Blann A.D., Lip G.Y. Anti-oxidative properties of beta-blockers and angiotensin-converting enzyme inhibitors in congestive heart failure. Eur Heart Fail 2003; 5 (2): 171-174.


Для цитирования:


Бернгардт Э.Р., Пармон Е.В., Трешкур Т.В., Шляхто Е.В. Тахииндуцированная кардиомиопатия: клинико-патогенетические аспекты. Артериальная гипертензия. 2008;14(1-S2):48-53.

Просмотров: 143


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1607-419X (Print)
ISSN 2411-8524 (Online)